Investing in Healthcare and Biotechnology

CEF INSIGHTS

English - April 01, 2016 21:00 - 8 minutes - 7.88 MB - ★★★★ - 5 ratings
Investing Business Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Quarterly CEFA Conference Call

Next Episode: Quarterly Conference Call

TEKLA Capital Management LLC's Daniel R. Omstead, Ph.D., President and Chief Executive Officer, discusses:
• The appeal of the biotechnology sector
• Opportunities in pre-public venture companies
• The Affordable Care Act and other factors influencing healthcare investing
• Why TEKLA is using a closed-end fund structure